非薬理学的介入の評価における同等性および非劣等性試験:論理的根拠,課題および勧告
1Division of Family Medicine and Primary Care, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden erland.axelsson@ki.se.
BMJ open
|August 31, 2025
まとめ
この記事では,非薬理学的介入を比較するための同等性および非劣等性試験の設計を紹介しています. 正確な研究結果を出すのに不可欠な 利点を確立し 統計力を維持するなどの課題を論じています
科学分野:
- 臨床試験の方法論
- 証拠 に 基づく 実践
- 医療サービス研究
背景:
- ランダム化臨床試験では 非薬理学的介入が比較されることが増えています
- 基準基準に対する同等性または非劣等性の評価は,共通の試験目標です.
研究 の 目的:
- 同等性および非劣等性試験の設計に アクセシブルな入門を提供すること.
- これらの設計に特有の課題と脅威について,特に非薬理学研究について議論する.
主な方法:
- 主な設計要素:仮説の選択,比較器の選択,およびマージンの定義について説明します.
- 同等性および非劣等性試験の共通分析方法をレビューする.
- プラセボ効果や統計力などの非薬学的環境における課題を強調する.
主要な成果:
- 同等性試験と劣等性試験は 明確な利点を持ちながら 独特の課題も抱えています
- 利益率の確立と統計力の達成の困難は,非薬理学研究において顕著である.
- 脅威には,介入の不十分な実施,報告のバイアス ("スピン"),間接的な証拠が含まれます.
結論:
- 方法論的厳しさは,有効な同等性および非劣等性試験に不可欠です.
- 特定された脅威を軽減するための非薬理学的介入については,特別な考慮が必要である.
- この研究分野での発見の信頼性を高めるための提案が提供されています.
関連する概念動画
Bioequivalence: Overview
1.2K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Clinical Trials
7.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.8K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Crossover Experiments
3.0K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
3.0K
Cochran's Q Test
544
Cochran's Q Test is a nonparametric statistical test used to determine if there are potential differences in the outcomes of three or more related groups on a binary (yes/no) or dichotomous outcome. It is essentially an extension of the McNemar Test, which is limited to two related samples - Cochran's Q test can handle three or more related samples, making it more versatile in scenarios where subjects are measured under multiple conditions. The test statistic follows a Chi-Square...
544


